中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Resistance to apoptosis should not be taken as a hallmark of cancer

文献类型:期刊论文

作者Wang RuiAn1; Li ZengShan1; Yan QingGuo1; Bian XiuWu1; Ding YanQing1; Du Xiang2; Sun BaoCun1; Sun YunTian3; Zhang XiangHong1
刊名CHINESE JOURNAL OF CANCER
出版日期2014
卷号33
ISSN号1000-467X
关键词BREAST-CANCER PROGNOSTIC-SIGNIFICANCE BCL-2 EXPRESSION GROWTH TUMORIGENESIS REGULATORS MARKER CELLS Cancer apoptosis Bcl-2 hallmark
其他题名Resistance to apoptosis should not be taken as a hallmark of cancer
英文摘要In the research community, resistance to apoptosis is often considered a hallmark of cancer. However, pathologists who diagnose cancer via microscope often see the opposite. Indeed, increased apoptosis and mitosis are usually observed simultaneously in cancerous lesions. Studies have shown that increased apoptosis is associated with cancer aggressiveness and poor clinical outcome. Furthermore, overexpression of Bcl-2, an antiapoptotic protein, is linked with better survival of cancer patients. Conversely, Bax, CD95, Caspase-3, and other apoptosis-inducing proteins have been found to promote carcinogenesis. This notion of the role of apoptosis in cancer is not new; cancer cells were found to be short-lived 88 years ago. Given these observations, resistance to apoptosis should not be considered a hallmark of cancer.
语种英语
CSCD记录号CSCD:5085880
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/46582]  
专题中国科学院合肥物质科学研究院
作者单位1.中国科学院大连化学物理研究所
2.复旦大学
3.中国科学院合肥物质科学研究院肿瘤医院
推荐引用方式
GB/T 7714
Wang RuiAn,Li ZengShan,Yan QingGuo,et al. Resistance to apoptosis should not be taken as a hallmark of cancer[J]. CHINESE JOURNAL OF CANCER,2014,33.
APA Wang RuiAn.,Li ZengShan.,Yan QingGuo.,Bian XiuWu.,Ding YanQing.,...&Zhang XiangHong.(2014).Resistance to apoptosis should not be taken as a hallmark of cancer.CHINESE JOURNAL OF CANCER,33.
MLA Wang RuiAn,et al."Resistance to apoptosis should not be taken as a hallmark of cancer".CHINESE JOURNAL OF CANCER 33(2014).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。